Metabolic risk factor profile associated with use of second generation antipsychotics: a cross sectional study in a community mental health centre

Table 3 Metabolic profile

	Reference N = 36	Clozapine N = 6	Risperidone N = 20	Olanzapine N = 31	Quetiapine N = 19	df	F(H)	P
*Glucose (mg/dl)**	85.8 ± 10.3	99.67 ± 14.5	95.2 ± 18.6	91.4 ± 14.1	97.2 ± 15.7	4(105)	2.9	0.026
*Cholesterol (mg/dl)**	209.3 ± 39.1	223.0 ± 45.9	213.4 ± 41.2	215.8 ± 41.9	237.6 ± 46.9	4(105)	1.3	0.277
Triglycerides(mg/dl)**	75(60.122)	194.5 (108–205)	145 (108–207)	105 (84–143)	161 (92–244)	4(110)	18.9	0.001
BMI		35.3 ± 6.4	29.1 ± 5.9	26.7 ± 5.3	29.3 ± 5.2	3(69)	4.6	0.005

* Means values adjusted fro age and previous treatments are given for glucose and cholesterol (Anova analysis);
** Unweighted median values, first and last quartile are given for triglycerides.(Kruskal Wallis: df 4(110), H = 18.9 p = 0.0008)

ISSN: 1471-244X